"Recapture
Your Perfect Health the Natural Way"
|
"Recapture
Your Perfect Health the Natural Way" |
|
BIOTHERAPEUTICS () INTESTINAL MICROFLORA Their role in your patients’ health
A healthy digestive tract is essential for the
human body to function
effectively There are some 10¹³ or more bacteria in the human intestines,
with a total mass of approximately 1,5 kg.
Over 400 species, both pathogenic and symbiotic, inhabit this region.
However, only a few of the symbiotic species possess the beneficial
qualities necessary to maintain a healthy digestive tract. The effect of diet and life-style on intestinal microflora Changes in life-style have allowed harmful bacteria to become
dominant in the modern human digestive tract, particularly among affluent
communities in developed countries. In fact, it has been found that the
present-day ecology of the human gastrointestinal tract is vastly different from
that of humans living in earlier times.
Factors such as incorrect diet, stress, environmental pollution and
insufficient exercise are known to have detrimental effects on the intestinal
microflora. Another important factor, which causes imbalances of the
intestinal flora, is the extensive use of antibiotics over the past 50 years.
Not only have antibiotics played a major role in decreasing the number of
beneficial bacteria residing in the intestinal tract, but also pathogenic
bacteria have developed resistance to many antibiotics, and this has allowed
them to proliferate at dangerous rates. Imbalances in the ecology of the gastro-intestinal tract cause patients to suffer from common intestinal disorders such as dyspepsia, constipation, distention and chronic diarrhoea. Biological control Health professionals and an informed general public are
becoming increasingly aware of these problems.
Many already favour biological control of the intestinal pathogenic
microorganisms using beneficial bacterial flora, which is naturally antagonistic
to the pathogens. The beneficial bacteria Two major groups of bacteria, which occur naturally in
the healthy human intestinal tract, are particularly beneficial for the
maintenance of a healthy digestive tract. They are: Lactobacillus,
which resides predominantly in the small intestine
and Bifidobacterium, which resides in the large intestine. Moreover, these two groups of microorganisms are closely
associated with each other. Lactobacilli, which are micro-aerophilic, reduce
the level of oxygen in their immediate surroundings, thus creating a favorable
environment for Bifidobacteria,
which are anaerobic inhabitants. The ability of these bacteria to colonize the human intestines is an important mechanism provided by nature to prevent the dominance of pathogenic microorganisms and protect against other health risks. Products supplied by BIOFLORA BIOFLORA’s products are conveniently supplied in gelatin
capsules and provide the required mega doses of the probiotic bacteria, which
were originally isolated from healthy human intestines. PRODUCT: ► INTESTIFLORA capsules, each containing: 1 (one) billion viable cells of
Lactobacillus acidophilus, Bifidobacterium
bifidum
and
Bifidobacterium
longum Suggested dose: Restoration dose: 1 to 2 capsules three times a day for 1 to 2 weeks. Maintenance dose: 1 to 3 capsules per day as required (see leaflets). Capsules should be taken preferably on an empty stomach or 30
minutes before meals with a glass of water. In severe cases of chronic abnormalities, probiotic treatment
should last for at least several weeks, accompanied by careful monitoring and
initial supportive treatment. It may sometimes be necessary to tailor specific products to suit individual patients’ needs. This service is available through BIOFLORA. Each batch of BIOFLORA’s products
undergoes stringent quality control tests and is accompanied by a certificate,
which states the number of viable bacteria per capsule and confirms the absence
of microorganisms indicative of faecal contamination.
|
| Home Introduction Distributors Product Range Stop en Voorkom Frequently Ask Questions Evaluation and Comments Author information goes here.
|
